HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiovascular status of carriers of the apolipoprotein A-I(Milano) mutant: the Limone sul Garda study.

AbstractBACKGROUND:
Carriers of the apolipoprotein A-I(Milano) (apoA-I(M)) mutant present with very low plasma HDL cholesterol and moderate hypertriglyceridemia, apparently not leading to premature coronary heart disease. The objective of this study was to establish whether this high-risk lipid/lipoprotein profile is associated with structural changes in the carotid arteries and heart, indicative of preclinical atherosclerosis.
METHODS AND RESULTS:
Twenty-one A-I(M) carriers were compared with age- and sex-matched control subjects from the same kindred and with 2 series of matched subjects with primary hypoalphalipoproteinemia (HA). Structural changes in the carotid arteries were defined as the intima-media thickness (IMT) measured by B-mode ultrasound. HA subjects, both recruited among patients attending our Lipid Clinic and blood donors, showed significant thickening of the carotids (average IMT, 0.86+/-0.25 and 0.88+/-0.29 mm, respectively) compared with control subjects (average IMT, 0.64+/-0.12 mm); the apoA-I(M) carriers instead showed normal arterial thickness (average IMT, 0.63+/-0.10 mm). Moreover, a significantly higher prevalence of atherosclerotic plaques was found in patients and blood donors with HA (both 57%) compared with apoA-I(M) carriers (33%) and control subjects (21%). Echocardiographic findings and maximal treadmill ECG did not differ significantly between apoA-I(M) carriers and control subjects, apart from a slight increase in left ventricular end-diastolic dimension in the carriers.
CONCLUSIONS:
Despite severe HA, carriers of the apoA-I(M) mutant do not show structural changes in the arteries and heart, in contrast to HA subjects, who are characterized by a marked increase in carotid IMT and increased prevalence of atherosclerotic plaques.
AuthorsC R Sirtori, L Calabresi, G Franceschini, D Baldassarre, M Amato, J Johansson, M Salvetti, C Monteduro, R Zulli, M L Muiesan, E Agabiti-Rosei
JournalCirculation (Circulation) Vol. 103 Issue 15 Pg. 1949-54 (Apr 17 2001) ISSN: 1524-4539 [Electronic] United States
PMID11306522 (Publication Type: Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Cholesterol, LDL
  • Cholesterol, VLDL
  • Lipoproteins, HDL
  • Triglycerides
  • apolipoprotein A-I Milano
  • Cholesterol
Topics
  • Adult
  • Apolipoprotein A-I (blood, genetics)
  • Cardiac Output (genetics)
  • Carotid Arteries (diagnostic imaging)
  • Carotid Artery Diseases (blood, diagnosis)
  • Cholesterol (blood)
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Cholesterol, VLDL (blood)
  • Echocardiography
  • Electrocardiography
  • Exercise Test
  • Female
  • Heterozygote
  • Humans
  • Hypertriglyceridemia (blood, diagnosis, genetics)
  • Lipoproteins, HDL (blood, deficiency, genetics)
  • Male
  • Triglycerides (blood)
  • Tunica Intima (diagnostic imaging)
  • Tunica Media (diagnostic imaging)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: